Essayer OR - Gratuit

Capex Target Should Be Set At 3.1% Of GDP

Mint New Delhi

|

January 28, 2025

GDP growth slowed to 6.0% in H1 FY25 from 8.2% in FY24, partly driven by a slump in capex

- Ramnath Krishnan

India's recent growth outcomes have been shaped to a significant extent by the Government of India's (GoI) capital expenditure. The post-pandemic recovery in real GDP growth was supported by large expansions in the GoI's capex, to the tune of ~30% per annum during FY21-24. As a proportion of GDP, such capital spending had nearly doubled to 3.2% in FY24 from 1.7% in FY20, although a part of this is admittedly on account of off-budget capex that has now come on budget.

Likewise, the recent slowdown in GDP growth, to 6.0% in H1 FY25 from 8.2% in FY24, has been partly driven by a slump in the GoI's capital expenditure, which has witnessed a double-digit decline during this period, owing to the general elections in Q1 and the excess rainfall during the monsoon. Consequently, the GoI capex-to-GDP ratio fell to 2.7% during this period, i.e., H1 FY25.

Given this context, ramping up the GoI's capex would play an important role in supporting growth outcomes in the near term, particularly when considerable global uncertainties abound and could pose downside risks to GDP expansion in FY26.

PLUS D'HISTOIRES DE Mint New Delhi

Mint New Delhi

Mint New Delhi

How CCI plans to watch AI use by companies

The Competition Commission of India (CCI) on Monday proposed a self-audit for companies to keep track of how they use artificial intelligence (AI) and the data they train AI models on. Implementing such a practice comes with multiple caveats. Mint explains.

time to read

2 mins

October 08, 2025

Mint New Delhi

Mint New Delhi

NAVIGATING A JOB LOSS IS NOT AS HARD AS IT SEEMS, BUT YOU SHOULD START EARLY

The best time to mend the roof is when the sun is shining, not after the rains commence. There is so much wisdom in this one sentence that it needs careful reflection. People expect life to be a smooth, sedate, upward ride, but it is anything but that. In fact, every facet of life has its ups and downs - sometimes, they are positive and at other times, they may be challenging.

time to read

3 mins

October 08, 2025

Mint New Delhi

US TARIFF-LED RISKS PERSIST FOR INDIA

The Indian economy stumbled in August, hit by the US's additional 25% tariffs on top of the 25% reciprocal levy, as external risks weighed on domestic momentum through a weakening rupee, continued selling by foreign investors, sliding stock market and slowing exports.

time to read

3 mins

October 08, 2025

Mint New Delhi

Nykaa fashion arm sashays again—spotlight on the stride

The fashion business of FSN E-Commerce Ventures Ltd (Nykaa) is showing signs of revival after several quarters of modest performance.

time to read

1 mins

October 08, 2025

Mint New Delhi

Mint New Delhi

‘RBI focusing on new use cases for e-rupee’

The Reserve Bank of India (RBI) is in no rush to open up the pilots for the central bank digital currency (CBDC) to the masses and is, instead, focusing on adding more use cases to the e-rupee with a focus on cross-border transactions, T. Rabi Sankar, deputy governor of the central bank, said on Tuesday.

time to read

1 mins

October 08, 2025

Mint New Delhi

Nobel physics prize goes to pioneers of quantum mechanics

US-based scientists John Clarke, Michel Devoret and John Martinis won the 2025 Nobel Prize in Physics for “experiments that revealed quantum physics in action”, paving the way for the development of the next generation of digital technologies.

time to read

1 min

October 08, 2025

Mint New Delhi

Nvidia to continue sponsoring H-1B visas

Chipmaker Nvidia's CEO Jensen Huang said that the company will continue to sponsor H-IB visas and cover all associated costs following U.S. President Donald Trump's executive order last month that imposed a $100,000 fee on each new application, Business Insider reported on Tuesday.

time to read

1 min

October 08, 2025

Mint New Delhi

AstraZeneca to sell cancer drug in India

AstraZeneca Pharma on Tuesday said it has received approval from the national drug regulator to market a cancer treatment drug in the country.

time to read

1 min

October 08, 2025

Mint New Delhi

Fintech lending growth slows after clampdown

But delinquency and deep-stage stress are still elevated, shows report

time to read

2 mins

October 08, 2025

Mint New Delhi

CENTRAL BANK OF INDIA RATED INDIA INVOLVED BY SKOCH FOR TRANSFORMING RECRUITMENT ONBOARDING DIGITALLY

The Central Bank of India has undertaken a landmark initiative to reimagine its recruitment and onboarding practices through a comprehensive digital solution.

time to read

1 mins

October 08, 2025

Listen

Translate

Share

-
+

Change font size